Back
Mativ Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
37
MATV
Mativ Holdings
Last Price:
16.95
Seasonality Move:
1.57%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.06
Seasonality Move:
-0.9%
Sell
37
Mativ Holdings (MATV)
is a Sell
Is Mativ Holdings a Buy, Sell or Hold?
- The current Mativ Holdings [MATV] share price is $16.96. The Score for MATV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- MATV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.10. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MATV Stock Price Chart
What is Mativ Holdings's stock price today?
-
The Mativ Holdings share price today is $16.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MATV is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.10
The current trend is relatively stagnant and RARE is experiencing slight selling pressure.
MATV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 45.07 | Sell |
| Chaikin Money Flow: | -157984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.72 - 18.02) | Sell |
| Bollinger Bands (100): | (15.25 - 19.05) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 51.24 | Buy |
| Chaikin Money Flow: | -456859 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.82 - 42.02) | Buy |
| Bollinger Bands (100): | (40.72 - 48.76) | Sell |
MATV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.07 | Sell |
| 20-day SMA: | 17.12 | Sell |
| 50-day SMA: | 17.77 | Sell |
| 200-day SMA: | 15.4 | Buy |
| 8-day EMA: | 17.04 | Sell |
| 20-day EMA: | 17.24 | Sell |
| 50-day EMA: | 17.42 | Sell |
| 200-day EMA: | 16.73 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.66 | Buy |
| 20-day SMA: | 40.71 | Buy |
| 50-day SMA: | 41.45 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 40.42 | Buy |
| 20-day EMA: | 40.54 | Buy |
| 50-day EMA: | 41.75 | Sell |
| 200-day EMA: | 43.31 | Sell |
Mativ Holdings Earnings Growth & MATV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.07 per share, and an increase next year of $0.73 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Mativ Holdings Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||